Placeholder Banner

SB 539 complaint

September 1, 2017
Download Full Comments Below
[Doc 1] Complaint, Civil Case Cover Sheet, Summons - Version 1
SB 539 complaint
Discover More
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
BIO comments on a proposed rule to restrict planting of GE organisms on national wildlife refuge lands. 
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.